Literature DB >> 28190291

Systematic review of a patient care bundle in reducing staphylococcal infections in cardiac and orthopaedic surgery.

Ning Ma1, Alun Cameron1, David Tivey1, Nikki Grae2, Sally Roberts3, Arthur Morris3.   

Abstract

Surgical site infections (SSIs) are serious adverse events hindering surgical patients' recovery. In Australia and New Zealand, SSIs are a huge burden to patients and healthcare systems. A bundled approach, including pre-theatre nasal and/or skin decolonization has been used to reduce the risk of staphylococcal infection. The aim of this review is to assess the effectiveness of the bundle in preventing SSIs for cardiac and orthopaedic surgeries. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Published literature was searched in PubMed, Embase and Cochrane Library of Systematic reviews. Identified articles were selected and extracted based on a priori defined Population-Intervention-Comparator-Outcome and eligibility criteria. Data of randomized controlled trials (RCTs) and comparative observational studies were synthesized by meta-analyses. Quality appraisal tools were used to assess the evidence quality. The review included six RCTs and 19 observational studies. The bundled treatment regimens varied substantially across all studies. RCTs showed a trend of Staphylococcus aureus SSIs reduction due to the bundle (relative risk = 0.59, 95% confidence interval (CI) = 0.33, 1.06) with moderate heterogeneity. Observational studies showed statistically significant reduction in all-cause and S. aureus SSIs, with 51% (95% CI = 0.41, 0.59) and 47% (95% CI = 0.35, 0.65), respectively. No publication biases were detected. SSIs in major cardiac and orthopaedic surgeries can be effectively reduced by approximately 50% with a pre-theatre patient care bundle approach.
© 2017 Royal Australasian College of Surgeons.

Entities:  

Keywords:  zzm321990Staphylococcus aureuszzm321990; meta-analysis; patient care bundle; surgical site infection; systematic review

Mesh:

Year:  2017        PMID: 28190291     DOI: 10.1111/ans.13879

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

1.  The Association of Climatic Factors with Rates of Surgical Site Infections: 17 Years' Data From Hospital Infection Surveillance.

Authors:  Seven Johannes Sam Aghdassi; Frank Schwab; Peter Hoffmann; Petra Gastmeier
Journal:  Dtsch Arztebl Int       Date:  2019-08-05       Impact factor: 5.594

Review 2.  Pre-surgical Nasal Decolonization of Staphylococcus aureus: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2022-08-23

Review 3.  Barriers and facilitators to the successful development, implementation and evaluation of care bundles in acute care in hospital: a scoping review.

Authors:  D Gilhooly; S A Green; C McCann; N Black; S R Moonesinghe
Journal:  Implement Sci       Date:  2019-05-06       Impact factor: 7.327

4.  Determinants of orthopedic physicians' self-reported compliance with surgical site infection prevention: results of the WACH-trial's pilot survey on COM-B factors in a German university hospital.

Authors:  Ivonne Tomsic; Ella Ebadi; Frank Gossé; Ina Hartlep; Pamela Schipper; Christian Krauth; Bettina Schock; Iris F Chaberny; Thomas von Lengerke
Journal:  Antimicrob Resist Infect Control       Date:  2021-04-07       Impact factor: 4.887

5.  Antibiotic Use, Incidence and Risk Factors for Orthopedic Surgical Site Infections in a Teaching Hospital in Madhya Pradesh, India.

Authors:  Kristina Skender; Anna Machowska; Vivek Singh; Varun Goel; Yogyata Marothi; Cecilia Stålsby Lundborg; Megha Sharma
Journal:  Antibiotics (Basel)       Date:  2022-05-31

Review 6.  Trends in Managing Cardiac and Orthopaedic Device-Associated Infections by Using Therapeutic Biomaterials.

Authors:  Stefania Scialla; Giorgia Martuscelli; Francesco Nappi; Sanjeet Singh Avtaar Singh; Adelaide Iervolino; Domenico Larobina; Luigi Ambrosio; Maria Grazia Raucci
Journal:  Polymers (Basel)       Date:  2021-05-12       Impact factor: 4.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.